ReviewDiscover oncology2024

Small molecule tyrosine kinase inhibitors approved for systemic therapy of advanced hepatocellular carcinoma: recent advances and future perspectives.

Jianzhong Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.